Huakang Pharma's revenue up 38% due to increased demand and production capacity

Summary: Huakang Pharma's revenue in 2022 rose 38% due to increased demand and sorbitol and crystalline maltitol capacities, and sales revenue of its crystalline sugar alcohols saw a YoY increase of 46%.On 24 March, Zhejiang Huakang Pharmaceutical Co...

Sweeteners China News 202304

www.cnchemicals.com